Isabela Mayá Wayhs Silva

Isabela Mayá Wayhs Silva

Auto-generated profile, based on publicly available information

Isabela Mayá Wayhs Silva

Department of Medical Genetics and Genomic Medicine, Faculty of Medical Sciences, State University of Campinas (Unicamp), Rua Tessália Vieira de Camargo, 126, Campinas, SP, 13083-887, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in Jornal de Pediatria
Verified
Journal Article
Open access
ISIsabela Mayá Wayhs Silva
Isabela Mayá Wayhs Silva
MTMilena Atique Tacla
Milena Atique Tacla
ERErlane marques Ribeiro
Erlane marques Ribeiro
ELElaine Lustosa-Mendes
Elaine Lustosa-Mendes
AFAgnes Cristina Fett-Conte
Agnes Cristina Fett-Conte
VGVera Lúcia Gil-da-Silva-Lopes
Vera Lúcia Gil-da-Silva-Lopes
The current study delves into the accessibility of genetic evaluations for individuals with orofacial clefts (OC), comparing data between genetics and treatment centers across Brazil. This cross-sectional retrospective study analyzed primary data from 1463 OC individuals registered in the Brazilian Database of Craniofacial Anomalies (BDCA) between 2008 and 2018 without age or sex selection. Diagnostic exam results stemming from research projects until 2023 were considered. Of the 1463 individuals with typical OC, 987 were non-syndromic, 462 were syndromic (SOC), 10 presented atypical forms, and three were not specified OC cases. The average age for accessing laboratory diagnosis was 8.5 years among SOC individuals. Notably, more SOC cases were registered in genetics centers than treatment and rehabilitation centers (37.1 % vs. 29 %, p = 0.0015). Those originating from genetics centers accessed diagnosis at an average age of 7.3 years, while those from treatment and rehabilitation centers experienced delays with an average age of 10.7 years (p = 0.0581). Irrespective of the center of origin, the data highlight delayed diagnosis and challenges in accessing genetic tests for the syndromic group. Given the widespread reliance on the public health system by most of the Brazilian population, disseminating this data can significantly contribute to shaping an informed perspective on healthcare access. These insights can improve public policies tailored to the unique needs of individuals with OC.

13 March 2023 in JMIR Preprints
Verified
Preprint
Open access
ISIsabela Mayá Silva
Isabela Mayá Silva
VLVera Lucia Lopes
Vera Lucia Lopes
BACKGROUND Health-related data available online is the most used source of information. In Brazil, more than 80% of its population uses the Internet for this purpose, particularly those diagnosed with a rare multisystem genetic disease, such as 22q11.2 Deletion Syndrome (22Q11.2 DS). This is primarily due to the lack of knowledge on the part of physicians and incomplete information received during routine consultations. However, one of the risks associated with online health data is that it lacks scientific validation. OBJECTIVE To improve access to trusted information, this study aims to evaluate the potential use of social media in Brazil as disseminators of scientific knowledge regarding 22q11.2 DS. METHODS Two social media accounts were created with the name @science.sd22q11.2, one on Instagram, and the other on Facebook RESULTS During the one year (2020-2021) of accounts activity, the majority of followers were females (80-90%), aged 35-44 years from Southeast (18.1%). The most frequently used words relevant to healthcare in posts with the highest reach on both pages include velopharyngeal insufficiency, speech, immunological changes, lymphocytes, and psychiatric disorders. CONCLUSIONS The absence of a record of followers from the North and Northeast restricts the potential use of the internet for scientific dissemination in Brazil. The low diversity of followers points to the use of the internet as a predictor of topics associated with 22q11.2 DS which deserve extra attention during medical care. Furthermore, these results serve as an additional indicator of the difficulty of accessing molecular diagnosis in association with illiteracy rates in the North and Northeast.

20 May 2026 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
DFDéborah Domeneghetti de Francisco
Déborah Domeneghetti de Francisco
ISIsabela Mayá Wayhs Silva
Isabela Mayá Wayhs Silva
CSCarlos Eduardo Steiner
Carlos Eduardo Steiner
VGVera Lúcia Gil-da-Silva-Lopes
Vera Lúcia Gil-da-Silva-Lopes
Background: This study aimed to describe different aspects of access to health care in a population attended by a clinical genetics service. Methods: This is a cross-sectional, descriptive, prospective, and exploratory study that included individuals followed for 10 consecutive months. Data were collected through standardized interviews and medical record review. The interviews addressed socioeconomic factors, access to medical genetics consultation and diagnostic investigations, health literacy, and social integration. Results: Of 200 participants, 18.5% reported difficulty accessing the geneticist. In 50.5% of the patients, the mean age at referral was 8.41 years, with a predominance of multiple congenital anomalies (43%) and neurodevelopmental disorders (32.5%) as justification for referral for consultation. A total of 50.5% of participants stated they did not understand the cause of their condition, and 57.5% were aware of possible comorbidities. In total, 74.7% attend regular educational institutions, and 48.7% need a tutor; for 32.4% of these, this demand has been open for 32.47 months (median = 12; SD = 33.95). A total of 37.4% of individuals aged 16 and over participate in the job market. Conclusion: This study highlights the restrictions on access to health care and the social integration of individuals treated at a Clinical Genetics service in the Brazilian population, as well as the difficulties faced by their caregivers. Although these are regional data, it is possible to recognize universal similarities in the panorama presented. Thus, the results can contribute to reflections on the reality faced by this population group and the design of public policies.

12 February 2026 in Clinics
Verified
Journal Article
Open access
DFDéborah Domeneghetti de Francisco
Déborah Domeneghetti de Francisco
ISIsabela Mayá Wayhs Silva
Isabela Mayá Wayhs Silva
JSJorge M. Saraiva
Jorge M. Saraiva
CSCarlos Eduardo Steiner
Carlos Eduardo Steiner
VGVera Lúcia Gil-da-Silva-Lopes
Vera Lúcia Gil-da-Silva-Lopes
Neurofibromatosis type 1 is a systemic genetic disease with manifestations that include neurocognitive alterations. The disease's characteristics influence various areas of the lives of affected individuals, regardless of their place of residence. This study compares the experiences of a small group of patients with type 1 neurofibromatosis in two public hospitals in Brazil and Portugal. This is an exploratory, cross-sectional, and descriptive study. Patients of legal age or those responsible for underage patients were included in a health service in the Clinical Hospital of the State University of Campinas in Brazil and the Clinical Academic Center of Coimbra in Portugal. They answered an online form about quality of life and access to health. 18 participants were included, 13 Brazilians and 5 Portuguese. Most were female and had a mean age at diagnosis of 8.2-years. The mean age of Brazilians was 9.1-years for the first consultation with a geneticist and 15.5-years among Portuguese. The average number of professionals accessed was 4.5 among Brazilians and 3.8 among Portuguese. Small sample size, restricted temporal aspect, convenience bias of participants with internet access, and self-declaration of data by participants. Both Brazilians and Portuguese participants with neurofibromatosis type 1 presented similar difficulties regarding access to health. The differences found between the participants from both countries focus on access to medical geneticists and their health literacy. Expanding studies would help identify care priorities related to the specificities of NF1 that could improve the quality of life of affected individuals.